Phase-based versus non-phase-based psychological interventions for complex PTSD: a systematic review and meta-analysis.

Eur J PsychotraumatolApr 8, 2026 (epub)
Clinical ResearchPsychiatryOpen access

Yongjun Lee, Subin Park, Young-Eun Cho

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis compared phase-based psychological interventions with non-phase-based approaches for people with clinically significant complex PTSD symptoms, or PTSD with at least two disturbances-in-self-organization clusters. Across most outcomes, the review found no significant differences between phase-based and non-phase-based interventions, or between exposure and non-exposure approaches. Multi-phase interventions showed greater effects on PTSD symptoms, while phase-based, multi-phase, and exposure interventions showed greater improvement in affect regulation difficulties. The abstract reports no pooled effect sizes or other quantitative estimates.

Key findings

  • Across most outcomes, phase-based and non-phase-based interventions did not differ significantly.
  • Multi-phase interventions had superior effects on PTSD symptoms compared with single-phase interventions.
  • Phase-based, multi-phase, and exposure interventions showed greater improvement in affect regulation difficulties than their respective comparators.

Why it matters

The findings inform the ongoing question of whether stabilization must precede trauma-memory exposure in treatment for complex PTSD. The lack of clear differences across most outcomes suggests that structured phase-based or exposure-based approaches are not uniformly superior, while the reported outcome-specific advantages indicate that intervention design may matter for particular symptoms.

What to keep in mind

The review was limited by the small number of available trials, assessment at a single time point, and heterogeneity in outcome measures, constraining subgroup comparisons and the precision of effect estimates.

Source

Published in Eur J Psychotraumatol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.